The Mesothelioma Center News - Page 3
Mesothelioma Treatment Guidelines Not Followed Often Enough
- by Tim Povtak
- Treatment & Doctors
- Jun 12, 2019
Too many patients with pleural mesothelioma are going without treatment recommended by National Comprehensive Cancer Network guidelines, according to a recent study at Cedars-Sinai Medical Center in Los Angeles.
Read More
Claire’s Recalls JoJo Siwa Makeup over Asbestos Contamination
- by Matt Mauney
- Asbestos Exposure & Bans
- Jun 7, 2019
For the second time in three months, Claire’s stores issued a voluntary recall over concerns of asbestos contamination in its makeup products marketed to young girls, the U.S. Food and…
Read More
Study Finds Modest Reality of Immunotherapy for Cancer
- by Tim Povtak
- Research & Clinical Trials
- Jun 6, 2019
Less than 13% of cancer patients who receive checkpoint inhibitor drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) actually benefit from the much-heralded form of immunotherapy, new research shows.
Read More
Johnson & Johnson Hit with $325M Verdict in Talc-Mesothelioma Case
- by Tim Povtak
- Legislation & Litigation
- Jun 3, 2019
A state jury in New York ordered Johnson & Johnson to pay $300 million in punitive damages to Donna Olson and her husband who claim its talcum powder caused her…
Read More
FDA Approves First New Treatment for Mesothelioma in 15 Years
- by Matt Mauney
- Treatment & Doctors
- May 24, 2019
The U.S. Food & Drug Administration on Thursday approved Tumor Treating Fields, a therapy involving electric currents that disrupt cancer cell division and inhibit tumor growth, for the first-line treatment…
Read More
Quality of Life Still Good with HIPEC Surgery for Peritoneal Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- May 22, 2019
Surgical oncologist Dr. Edward Levine was not surprised by the encouraging results of the recent study measuring quality-of-life issues following aggressive treatment for patients with peritoneal mesothelioma. He has…
Read More
Mesothelioma Clinical Trial Exploring Family Predisposition
- by Tim Povtak
- Research & Clinical Trials
- May 20, 2019
The National Cancer Institute has opened a clinical trial using mesothelioma patients and their family members to explore predisposition to the cancer and potential solutions to…
Read More
Latest T-Cell Study Opens for Mesothelioma Patients
- by Tim Povtak
- Research & Clinical Trials
- May 16, 2019
Sarah Cannon Research Institute in Nashville, Tennessee, and MD Anderson Cancer Center in Houston have opened a much-anticipated clinical trial involving a novel T-cell therapy for patients with mesothelioma.
Read More
New Radiotherapy Can Double Two-Year Survival for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- May 14, 2019
A novel radiotherapy regimen can double the chances of surviving two or more years with pleural mesothelioma, according to Dr. Marco Trovo at University Hospital of Udine in…
Read More
Study: Elderly Mesothelioma Patients Denied Valuable Survival Time
- by Tim Povtak
- Research & Clinical Trials
- May 13, 2019
Almost two-thirds of the elderly patients being diagnosed with mesothelioma are dying without receiving any cancer-related treatment that could significantly extend survival. Median survival is just 4.1 months,…
Read More
